World Class Multi-Disciplinary Team
CEO & Founder
Three-time founder, with a background as a data scientist and quantitative engineer. Author of Hamiltonian Biology and The Dark Genome, where he develops the first-principles framework for treating RNA as biology's universal causal interface.
Chief Intelligence Officer & Co-Founder
Repeat founder who translates frontier AI research into deployable biological and commercial systems. PhD candidate at Korea University with deep expertise in ML engineering and large-model training.
Chief Science Officer
RNA biologist with deep experience translating transcriptomic science into commercial programs at Guardant Health and Veracyte. Combines molecular biology depth with the program-building discipline required to run rigorous wet-lab science at scale.
Principal Scientist - Organoids
Organoid scientist trained in the Hans Clevers lineage, the laboratory that invented organoid technology. Deep experience translating tissue models into predictive drug response systems.
Chief Technology Officer
Machine learning engineer with deep technical range across foundation models, graph neural networks, and large-scale ML systems. Master's in Computer Science from KAIST.
Chief People Officer
Operator and talent leader with prior experience at GIC, McKinsey & Company, and Antler, spanning sovereign capital and early-stage venture building.
Senior Engineer
ML engineer with hands-on experience building and deploying production AI pipelines for biological data. Holds a Master's in Computer Science from KAIST.
Leading global advisors across RNA, Biotech and Molecular Biology
Sterling Professor
Yale University
Sterling Professor at Yale, HHMI Investigator, and member of the National Academy of Sciences. Past-president of the RNA Society and founder of RNAConnect and RIGImmune, now serving as President of the Telluride Science Foundation.
Senior Pathologist
Korea University Hospital
Senior Clinical Pathologist and molecular diagnostics specialist bridging tissue-level disease interpretation with next-generation sequencing and translational oncology applications.
Chief Science Officer
Gene Company
Pioneering RNA scientist at QUT who discovered in 2004 that non-coding RNAs can functionally control gene transcription in human cells.
Professor
HUFS
Specializing in AI-driven drug discovery, digital health, and precision medicine at the intersection of bioinformatics and cheminformatics.
President & COO
Intelligene
A rare bridge between deep biological science and global business execution, with foundational training in biochemistry and pre-clinical drug development.
Professor of Hematopathology
MD Anderson Cancer Center
Professor at MD Anderson who founded its Molecular Diagnostics Laboratory and helped pioneer the clinical adoption of cancer genomics in molecular pathology practice.
Professor
SKKU
A leading authority on RNA-based precision oncology, pioneering circulating tumor RNA and non-coding RNA as clinical signals for cancer detection.
